Drug Trial Radar · NCT07306949
Real-Life Clinical Efficacy of Acoramidis in Participants With ATTR-CM and Association With Cardiac Biomarkers
Last checked: Nov 19, 2026Latest source record: Jan 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Oct 1, 2025
Primary completion
Mar 31, 2028
Study completion Mar 31, 2028
Sponsor
- Lead sponsor
- Alexion Pharmaceuticals, Inc.AstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Dec 29, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to confirm that the treatment with acoramidis prevents the deterioration of the ATTR-CM disease progression index and that these indexes are surrogate markers of disease progression.
Conditions
- Transthyretin-type Cardiac Amyloidosis
Interventions
AcoramidisDrug
Participants will receive acoramidis tablets orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease Progression Rate as Measured by N-terminal pro-brain-type Natriuretic Peptide (NT-proBNP) and/or Outpatient Diuretic Intensification (ODI)Time frame: Baseline through 12 months
Locations
16 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Bunkyō City, Japan · Not yet recruiting
Research Site
Bunkyō City, Japan · Not yet recruiting
Research Site
Kumamoto, Japan · Not yet recruiting
Research Site
Kurume-shi, Japan · Recruiting
Research Site
Kyoto, Japan · Not yet recruiting
Research Site
Mitaka-shi, Japan · Not yet recruiting
Research Site
Nagoya, Japan · Not yet recruiting
Research Site
Nankoku-shi, Japan · Not yet recruiting
Research Site
Okayama, Japan · Not yet recruiting
Research Site
Ōtsu, Japan · Not yet recruiting
Research Site
Sagamihara-shi, Japan · Not yet recruiting
Research Site
Sapporo, Japan · Not yet recruiting
Research Site
Shinjuku-ku, Japan · Not yet recruiting
Research Site
Suita-shi, Japan · Not yet recruiting
Research Site
Tsu, Japan · Not yet recruiting
Research Site
Yufu-shi, Japan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.